Ann Lin is a founding member and scientific advisor of Meliora Therapeutics. She is currently the co-founder of Cromatic, a techbio company that building next generation software for life-sciences companies, and a PhD candidate at Stanford University in the Department of Genetics. She is passionate about building high-throughput screening platforms and technologies that can accelerate the pace of therapeutic discovery.